戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  direct parasite killing agent and as a host immunostimulant.
2 tein combined either with AS02B or with AS15 immunostimulant.
3 onvergent construction of the potent saponin immunostimulant.
4 sing heterodimers of two covalently attached immunostimulants.
5  blood, suggesting that this fluid contained immunostimulants.
6  cells and further induced by treatment with immunostimulants.
7 were upcycled into soil amendments and plant immunostimulants.
8 ccess and engineer natural and new-to-nature immunostimulants.
9 euticals, drug delivery agents and potential immunostimulants.
10 ctions with the bladder microbiota and other immunostimulants.
11 wards the M1 or M2 states upon activation by immunostimulants.
12 odeficient mice, and after treatment with an immunostimulant; 1-methyl tryptophan.
13 recombinant MAGE-A3 protein combined with an immunostimulant (13 doses over 27 months) in completely
14                                         Many immunostimulants act as vaccine adjuvants via activation
15 ate-limiting for high output NO synthesis by immunostimulant-activated cells and represents a potenti
16 shown to possess antioxidant, antitumor, and immunostimulant activities.
17                             In this way, the immunostimulant activity of monophosphoryl lipid A can s
18 The derivatives show significantly different immunostimulant activity profiles from their respective
19 ed 18-carbon acyl chain that is critical for immunostimulant activity.
20                                      General immunostimulants (adjuvants) are essential for generatin
21 model can be achieved using a tumor-targeted immunostimulant and provides immunological insights that
22 osensor system to discover novel DC-targeted immunostimulants and unveil previously unrecognized (and
23  P = .06) and was less strong with the other immunostimulant AS02B (HR, 0.84; 95% CI, 0.36 to 1.97; P
24           This effect was strongest when the immunostimulant AS15 was included in the immunotherapy (
25 recombinant MAGE-A3 antigen combined with an immunostimulant (AS15 or AS02B).
26             Combining tumor antigens with an immunostimulant can induce the immune system to specific
27                                              Immunostimulants can be highly effective anti-cancer the
28 ignificant adverse events as a result of its immunostimulant capabilities.
29 mized phase II trial evaluated two different immunostimulants combined with the MAGE-A3 protein to in
30 lacement of FP with recombinant GM-CSF as an immunostimulant completely abrogated the selection of RC
31  radionuclide and a CpG oligodeoxynucleotide immunostimulant, driven by the thermally sensitive phase
32 hat ambient exposures to endotoxin and other immunostimulants during early life influence allergic ri
33           The optimized vaccine consisted of immunostimulants either adsorbed to or encapsulated with
34 dicinally important glycoprotein, used as an immunostimulant following bone-marrow transplant.
35 tudy confirms that zymosan can be used as an immunostimulant for microneedle vaccination.
36 investigated whether IL-10 could serve as an immunostimulant for specific CD8(+) cytotoxic T cell (CT
37 sts is attractive in the search of potential immunostimulants for cancer.
38 ation of dendritic cells via heterodimers of immunostimulants formed at a discrete molecular distance
39 not only revealed the origin, biogenesis and immunostimulant function of eccDNAs but also uncovered t
40 carrier/adjuvant in vaccines and nonspecific immunostimulant in cancer.
41 d that eccDNAs can function as potent innate immunostimulants in a manner that is independent of eccD
42 used as carriers, adjuvants, and nonspecific immunostimulants in cancer because they promote Th1 immu
43                                 These potent immunostimulants, including defensins, cathelicidin, eos
44   Moreover, functional GFRP is expressed and immunostimulant-induced BH4 accumulates in sufficient qu
45                                  Formulating immunostimulants into nanoparticle systems can potential
46  the study of inflammation using traditional immunostimulants is complicated by paracrine and autocri
47 e oncotherapeutic promise of IL-15, a potent immunostimulant, is limited by a short serum t (1/2) The
48 cated in Alzheimer's disease, and the potent immunostimulant KRN7000.
49 ify VSA-2 (5b) as another MS-based promising immunostimulant lead owing to its distinctive ability in
50 amuscular injections of recMAGE-A3 with AS15 immunostimulant (MAGE-A3 immunotherapeutic) or placebo d
51 lated with an oil-in-water emulsion plus the immunostimulants monophosphoryl lipid A and the saponin
52                              BCG is a potent immunostimulant, normally producing a Th1 cytokine respo
53 cy ablation (RFA) with local injection of an immunostimulant, OK-432, resulted in improved survival w
54 unization with Ag in adjuvant, expression of immunostimulants on target tissues, or coexpression of T
55  anti-varicose medications, corticosteroids, immunostimulants (pegfilgrastim), opioids, analgesics, a
56 d medullary lymphatic organization following immunostimulant, Poly I:C, administration in vivo.
57 ion triggered in midpregnancy in mice by the immunostimulant polyriboinosinic-polyribocytidylic acid
58 safe yet effective systemically administered immunostimulant prodrugs for next-generation cancer immu
59 ver a wide range of concentrations, and show immunostimulant properties in human cells, promoting the
60 ve component of GPI-0100 responsible for its immunostimulant property.
61                         We hypothesized that immunostimulants released in vivo from C. albicans durin
62                                              Immunostimulants represent an emerging class of drugs fo
63 opolysaccharide (LPS; endotoxin) is a potent immunostimulant that can induce an acute inflammatory re
64 ltimately may have clinical utility as novel immunostimulants that could bolster the barrier defenses
65 s, such as mercury, are potent environmental immunostimulants that produce a number of immunopatholog
66  possible use of an enzyme hydrolyzate as an immunostimulant to Asian Seabass (Lates calcarifer).
67          Still, the popular use of "sterile" immunostimulants to initiate MIA has limited translation
68                                              Immunostimulants trigger vascular smooth muscle cells (V
69                          Therefore, the AS15 immunostimulant was selected for combination with the MA
70 ploring the mechanism of how STX5 acts as an immunostimulant, we have identified the de novo RNA-bind
71 ults suggest that GM-CSF-G250 FP is a potent immunostimulant with the capacity for activating immunom
72  easy access to structurally defined saponin immunostimulants with favorable adjvuant activity and lo